From Yahoo Finance: 2025-06-16 11:00:00

Regencell Bioscience Holdings shares surged 250% on June 16, 2025, following a 38-to-1 stock split. The Hong Kong-based biotech firm focuses on using traditional Chinese medicine to treat ADHD and ASD in children. The split aimed to increase liquidity and accessibility for investors, leading to a significant rise in share value.

Read more: Regencell Bioscience Stock Skyrockets as 38-to-1 Split Takes Effect